EUVIMEDEUVIMED entdecken
Crossref

Holmium (III)-doped multifunctional nanotheranostic agent for ultra-high-field magnetic resonance imaging-guided chemo-photothermal tumor therapy

Ruling Zhang, Meng Liu, Sitong Liu, Xiaotong Liang, Ruitao Lu, Xintao Shuai, Dalin Wu, Zhong Cao

Acta Biomaterialia · 2023

DOI: 10.1016/j.actbio.2023.10.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2023. Verfasst von Ruling Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, 518107, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Nanoparticles, Hyperthermia, Induced. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Science, Technology and Innovation Commission of Shenzhen Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ultra-high-field (UHF) MRI has shown great advantages over low-field magnetic resonance imaging (MRI). Despite being the most commonly used MRI contrast agents, gadolinium chelates perform poorly in high magnetic fields, which significantly weakens their T1 intensity. In comparison, the rare element Holmium (Ho)-based nanoparticles (NPs) have demonstrated great potential as T2-weighted MRI contrast agents in UHF MRI due to their extremely short electron relaxation times (∼ 10-13s). In this study, a multifunctional nanotherapeutic probe was designed for UHF MRI-guided chemotherapy and photothermal therapy. The Ho (III)-doped mesoporous polydopamine (Ho-MPDA, HM) nanosphere was loaded with the chemotherapeutic drug mitoxantrone (MTO) and then coated with 4T1 cell membranes to enhance active targeting delivery to breast cancer. The prepared nanotherapeutic probe MTO@HMM@4T1 (HMM@T) exhibited good biocompatibility, high drug-loading capability and great potential as Ho (III)-based UHF MRI contrast agents. Moreover, the biodegradation of HMM@T in response to the intratumor pH and glutathione (GSH) promotes MTO release. Near-infrared (NIR) light irradiation of HM induced photothermal therapy and further enhanced drug release. Consequently, HMM@T effectively acted as an MRI-guided tumor-targeting chemo-photothermal therapy against 4T1 breast cancer. STATEMENT OF SIGNIFICANCE: Ultra-high-field (UHF) MRI has shown great advantages over low-field magnetic resonance imaging (MRI). Although gadolinium chelates are the most commonly used MRI contrast agents in clinical practice, they exhibit a significantly decreased T1 relaxivity at UHF. Holmium exhibits outstanding UHF magnetic resonance capabilities in comparison with gadolinium chelates currently used in clinic. Herein, a theranostic nanodrug (HMM@T) was designed for UHF MRI-guided chemo-photothermal therapy. The nanodrug possessed remarkable UHF T2 MRI properties (r2 = 152.13 mM-1s-1) and high drug loading capability of 18.4 %. The biodegradation of HMM@T NPs under triple stimulations of pH, GSH, and NIR led to an efficient release of MTO in tumor microenvironment. Our results revealed the potential of a novel UHF MRI-guided multifunctional nanosystem in cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNanoparticlesHyperthermia, InducedHumansFemaleHolmiumPhotothermal TherapyContrast MediaTheranostic NanomedicineGadoliniumPhototherapyMagnetic Resonance ImagingDoxorubicinTumor Microenvironment

Stichwörter der Autor:innen

Breast cancerHolmium (III)Magnetic resonance imagingMesoporous polydopamineUltra-high-field

Substanzen

HolmiumContrast MediaGadoliniumDoxorubicin

Autor:innen und Institutionen

  • School of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, 518107, China.
  • Shenzhen International Institute for Biomedical Research, Silver Star Hi-tech Park, Longhua District, Shenzhen, Guangdong, 518116, China.
  • Nanomedicine Research Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, 510630, China.
  • School of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, 518107, China. Electronic address: wudlin6@mail.sysu.edu.cn.
  • School of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, 518107, China. Electronic address: caozhong@mail.sysu.edu.cn.

Förderung

  • Science, Technology and Innovation Commission of Shenzhen Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, R., Liu, M., Liu, S., Liang, X., Lu, R., Shuai, X., Wu, D., & Cao, Z. (2023). Holmium (III)-doped multifunctional nanotheranostic agent for ultra-high-field magnetic resonance imaging-guided chemo-photothermal tumor therapy. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2023.10.017

Vancouver

Zhang R, Liu M, Liu S, Liang X, Lu R, Shuai X, et al. Holmium (III)-doped multifunctional nanotheranostic agent for ultra-high-field magnetic resonance imaging-guided chemo-photothermal tumor therapy. Acta Biomaterialia. 2023. doi:10.1016/j.actbio.2023.10.017

BibTeX
@article{Zhang2023,
  author = {Zhang, Ruling and Liu, Meng and Liu, Sitong and Liang, Xiaotong and Lu, Ruitao and Shuai, Xintao and Wu, Dalin and Cao, Zhong},
  title = {Holmium (III)-doped multifunctional nanotheranostic agent for ultra-high-field magnetic resonance imaging-guided chemo-photothermal tumor therapy},
  journal = {Acta Biomaterialia},
  year = {2023},
  doi = {10.1016/j.actbio.2023.10.017}
}
Kostenlos starten →